 Participants naïve to treatment with subcutaneous SC interferons or oral Disease Modifying Therapy DMT who are about to start PLEGRIDY PEN therapy will be screened for participation in this Phase IV trial. Participants will remain on Plegridy therapy as prescribed by their physician. Plegridy will not be provided to participants by Biogen as a part of this study. 